Other
InnoCare (9969 HK) enters into a strategic collaboration and license agreement with Eli Lilly (LLY) and is eligible for up to USD 100mln upfront and USD 3.25bln in milestone payments
StockNow breaking-news AI analysis
InnoCare agreed to a strategic collaboration and license deal with Eli Lilly, granting eligibility for up to $100 million upfront and $3.25 billion in milestone payments.
Related stocks
1 stocks
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.